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Abstract 
Purpose: To explore community pharmacists’ perception of the sale of non-clinically proven 
health supplements and over-the-counter (OTC) products available in Penang, Malaysia.  
Methods: A cross-sectional survey using a self-completed postal questionnaire was 
conducted in July 2010 among 200 community pharmacists practicing in Penang Island.  
Results: Fifty six pharmacists participated in the study (response rate, 28.0 %). A total of 
10.7 % respondents indicated that the sale of non-clinically proven products result in high 
profit. Only 25.0 % of the pharmacists believed that non-clinically proven OTC products are 
effective, while 35.7 % thought that it is not ethical to sell these products. A majority of the 
respondents (94.7 %) agreed that manufacturers’ advertisement have a huge effect on 
positive consumers’ behaviour towards such products. Most respondents agreed that 
manufacturers of these products claim that their products are effective (57.1 %) and have few 
or no side effects (60.7 %). 
Conclusions: Pharmacists who participated in the study have mixed opinions on the efficacy 
and effectiveness of non-clinically proven products. There is a need for pharmacists to be 
well educated on the evidence-based use of these products in order to be able to offer 
appropriate advice to those who come to them to purchase the items.   
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Health supplements have received widespread 
acceptance amongst the general public in many 
parts of the world in recent years [1,2]. For a 
majority of the general public, health 
supplements are purchased mostly for self-
medication purposes [3].  In Malaysia, health 
supplements are largely sold as over-the-counter 
(OTC) products and can be readily obtained from 
community pharmacies, hyper-markets, health 
food stores, general provision shops, 
complementary and alternative medicine 
practitioners and also from direct selling 
companies. These supplements are generally 
sold as herbal or traditional remedies, tonics, 
vitamins, minerals or food supplements and 
many would have claims of being natural. 
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However, the clinical use and efficacy of these 
products are not supported with well randomised 
clinical trials and does not comprise an adequate 
assessment of safety [3,4]. Furthermore, most of 
these product manufacturers employ testimonials 
of users as part of their advertising strategy.  
 
Although  it is hard to provide accurate data on 
the use of non-clinically proven therapies in 
Malaysia, a recent local study published 
concluded that about 88.9% of the population 
(N= 6947) are using biological-based therapies, 
which included herbal therapy, vitamins and 
supplements for health problems [5]. 
Accordingly, the World Health Organization 
(WHO) had reported that the sales of traditional 
and complementary/alternative medicines in 
Malaysia are estimated to be RM 1 billion (US$ 
333 million) annually [6].  
 
The increasing demand for such products 
necessitates the community pharmacists to be 
well equipped with adequate and up to date 
information about these products. Besides, being 
an expert in medicinal products, they are also 
expected to be able to provide advice on the 
benefits and risk of using such preparations to 
consumers. Currently, there are no studies in 
Malaysia which focused on the community 
pharmacist’s beliefs towards the sale of non-
clinically products. Thus, the main aim of this 
study was to explore the community pharmacists’ 
perception towards the sale of the non-clinically 
proven health supplements and over-the-counter 





A cross-sectional survey using a self-completed 
postal questionnaire was conducted in the month 
of July 2010 among community pharmacists 
practicing in the state of Penang, Malaysia (N = 
200). The questionnaire was tested for its face 
and content validity by two experts. 
Subsequently, a pre-test was performed by 
assigning 15 community pharmacists to answer 
the questionnaire. Reliability analysis of the 
responses yielded a Cronbach’s Alpha value of 
0.644 and all of the items appeared to make a 
valid contribution to the overall score.  
 
The final questionnaire comprised two sections. 
The first section assessed the demographic 
characteristics of the respondents. The second 
section evaluated the pharmacists’ perceptions 
towards the sale of non-clinically proven health 
supplements and OTC. Additionally, the reasons 
for selling those products were also explored. 
The questions in this section were framed into a 
3-point Likert scale (1 = disagree, 2 = neutral, 3 = 
agree).  
The questionnaires were posted along with a 
prepaid return envelope to the respondents. A 
follow up reminder letter was sent to the non-
respondents after two weeks to increase the 
response rate. The participation of the 
pharmacist involved was voluntary. Informed 
consent was obtained and anonymity was 
guaranteed. All the collected data were entered 




Upon completion of the survey period, 56 
responses were received (response rate of 
28.0%). The respondents were mostly female 
(62.5%) and aged between 30 to 39 years 
(53.6%). The demographic characteristics of the 
respondents are shown in Table 1. 
 
Table 1: Demographic characteristics of the 
respondents 
 








20 – 29  
30 – 39  























Duration of practice 
(years) 
1 – 3   
4 – 6  









In this survey, only 10.7 % of the respondents 
indicated that the sale of non-clinically proven 
OTC products generated high profit (Table 2). 
Interestingly, only 25.0 % of the pharmacists 
believed that non-clinically proven OTC products 
are effective, while 35.7 % thought that it is not 
ethical to sell these products. Nevertheless, a 
large proportion of the respondents sell these 
products in order to sustain their pharmacy 
business (57.4 %) or to compete with other 
pharmacies (50.0 %). About half (51.7 %) of the 
surveyed pharmacists perceived that there is 
high demand from the consumers regarding the 
non-clinically proven products. A majority of the 
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respondents (94.7 %) agreed that manufacturers’ 
advertisements influenced consumers’ choice of 
such products. The respondents mostly agreed 
that the manufacturers of these products claim 
that their products are effective (57.1 %) and 
have fewer or no side effects (60.7 %).  
 
Table 2: Pharmacists’ perceptions of the sale of non-clinically proven health supplements and over–
the-counter (OTC) products 
 
**DA = Disagree, N = Neutral, A = Agree);  *p < 0.05 
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Duration 
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The sale of non-clinical 
proven health supplement 
and (OTC) products will 
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proven OTC products in this 




















In order to sustain my 
pharmacy business, I need 
to sell various non-clinically 
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my customers towards the 


















Massive advertising by 
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OTC products have a very 
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ethical to sell all the non-
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products in my pharmacy 
because I need to compete 
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products able to treat 





















Most of my customers prefer 
the non-clinically proven 
products than other 
products or pharmaceuticals 
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Non-clinically proven preparations are widely 
accepted around the globe [7]. Perception of 
community pharmacists on the use of non-
clinically proven preparations cannot be 
undermined since these preparations are sold 
over-the-counter in pharmacies in most of the 
countries. These preparations are considered as 
“safe and natural” alternatives to conventional 
medicines and have been reported in earlier 
studies [8,9]. However results of this study reflect 
a mixed response regarding the efficacy of these 
preparations. The proportion of pharmacists who 
held negative beliefs of the products’ efficacy 
were almost equal to those who supported it. 
This finding differs from that of Kwan et al which 
reported that about 50 and 42 % of pharmacists 
believed that these preparations are not safe and 
most have a high degree of placebo effect 
respectively [10]. However, a study in California, 
USA reported that 48 % of pharmacists believed 
that alternative medications are effective [11]. 
  
Out of the total study respondents, 28.6% of 
them agreed that it is not unethical to sell these 
preparations in pharmacies. In a study by Fakeye 
and Adisa [12], majority of their study 
respondents stated that pharmacists should 
stock complementary medicines. 
 
About half of the respondents disagreed that 
sales from non-clinically proven health products 
bring them high profits. This contradicts the 
findings of Naidu [13] who reported that an 
increase in annual sales is predicted due to the 
availability of complementary medicines at their 
pharmacies. In a study by Bouldin et al, a 
majority of pharmacists agreed that the sales of 
herbal medicines have a high profit potential [14].  
Patient’s demand for non-clinically proven 
products was also reported by the study 
respondents. A proportion of the responding 
pharmacists   indicated that the high demand of 
OTC health supplements from the customer was 
the major reason of sales. This finding is 
consistent with a study conducted by Braun et al 
in which it was mentioned that complementary 
medicines are widely used by pharmacy 
customers of all ages and there is a high demand 
of these products [15].          
 
A key issue highlighted by the present study is 
the effect of advertisement of OTC products on 
consumer behaviour. Almost all respondents 
agreed that massive advertisements have a 
great influence on consumers. This is buttresses 
the study by Bell et al, who reported that 15   % 
of people were ready to terminate their 
relationship with their doctor if they refused their 
request for an advertised drug [16]. In another 
study, Basara found a significant increase in the 
number of new prescriptions for a product during 
and after it was advertised directly to consumers 
[17]. However, there is limited data focusing on 
the effect of advertisement of non-prescription 
medicines. In a study conducted in New Zealand, 
pharmacists reported that consumers request 
pharmacist-only medicines after watching the 
advertisements [18]. It can be concluded that 
advertisement is the major contributing factor to 
demand for non-clinically proven OTC products 
at pharmacies. 
 
Another important aspect related to non-clinically 
proven products is their use in chronic 
conditions. Approximately three out of five 
respondents did agree that manufacturers of 
these products do claim efficacy of their products 
in chronic illnesses. Further evidence on the use 
of complementary medicines comes from 
frequent studies in patients with serious chronic 
illnesses, including cancer [19] and HIV/AIDS 
[20]. However, the effect of claims offered by the 
manufacturers on consumer behaviour is not 
reported in these studies and there is no data 
available in the Malaysian context. 
 
In the present study, about half of the surveyed 
pharmacists disagreed that their consumers 
prefer non-clinically proven preparations over 
other products or pharmaceuticals in their 
pharmacies. Previously reported studies on the 
preferences of consumers for complementary 
medicines over conventional medicines portray a 
different situation. Patients’ choice of using non-
clinically proven products was attached to lack of 
effectiveness of other treatment and safety 
concerns [21]. Patients’ reasons for seeking 
complementary medicines in these studies 
suggest that conventional medicines have not 
met their needs. In a number of cases, these 
products may wholly or partly substitute 
conventional medicines such as in patients with 
cancer where it is clearly intended to be 
complementary to conventional care [21]. In 
Malaysian context, although the use of 
complementary medicines is quite common, 
conventional therapies still dominate the 
Malaysian society. Therefore, it can be 
hypothesized that consumers in Malaysia are still 
satisfied with conventional therapies as their 
needs are fulfilled and they feel safe in using 
conventional treatment. 
 
Within the context of the pharmacy profession, it 
is understood that preparation and dispensing of 
pharmaceutical products have high attraction for 
the pharmacists. Dispensing accounts for 
approximately 70% of the gross income of most 
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community pharmacies in developed countries 
[22]. However, in Malaysian health settings, 
dispensing and prescribing practices are not yet 
separated. The prescribers are therefore allowed 
to dispense and stock medications. At the 
pharmacies, only “Class C Poisons” (products 
that can only be sold as a dispensed medicine 
with entry in the prescription book) are dispensed 
by the pharmacist. As the pharmacists have less 
opportunity for supplying prescription medicines, 
they are forced to stock and sell products other 
than pharmaceuticals. This may include 
cosmetics and non clinical proven products. This 
observation is supported by the study results 
which showed that a third of the respondents 
agreed that they stock and sell non-clinically 
proven products for the sustainability of their 
pharmacies. This is further reflected by the study 
result where half of the surveyed pharmacists 
viewed that competition with other pharmacies 
was the major reason for them to promote such 
products. 
 
Limitations of the study 
 
This study has limitations which influenced the 
generalization of its findings. Whilst efforts were 
taken to recruit 200 pharmacists, it is possible 
that the mailing method for conducting the study 
was responsible for the low response rate and 
hence the recruited respondents do not fully 
represent all pharmacy customers. Limited data 
available from literature regarding the factors 
associated with pharmacists’ of non-clinically 
proven health supplements makes it difficult to 





The use of non-clinically proven preparations is 
widespread and established in many cultures 
and countries. Findings of the present study 
indicate that pharmacists who participated in the 
study have mixed opinions on the efficacy and 
effectiveness of non-clinically proven products. 
Therefore, community pharmacists should 
constantly educate themselves in order to be 
properly equipped to provide appropriate advice 
and counselling to those who use these 
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